Subject has clinically significant and uncontrolled major medical condition(s) including but not limited to:
Uncontrolled (over the last 30 days), clinically significant confounding medical conditions
Uncontrolled clinically significant arrhythmias.
Participant has clinically significant uncontrolled conditions.
Having clinically significant cardiac disease such as ventricular arrhythmia requiring therapy, uncontrolled hypertension or any history of symptomatic CHF
Symptomatic arrhythmia or any uncontrolled arrhythmia requiring ongoing treatment.
Serious arrhythmia,
Uncontrolled clinically significant arrhythmia, myocardial ischemia or congestive heart failure within the past 2 weeks, that is considered by the treating physician as a contraindication for initiation of chemotherapy;  discussion with the principal investigator is encouraged if further clarification is required
Absence of uncontrolled cardiac arrhythmia
Subjects with clinically apparent arrhythmia or arrhythmias who are not stable on medical management within two weeks of enrollment
Subjects with clinically apparent arrhythmia or arrhythmias who are not stable on medical management within two weeks of enrollment
Uncontrolled clinically significant cardiac arrhythmia
History of clinically significant (as determined by the treating physician) atrial arrhythmia or any history of ventricular arrhythmia
Subject has a clinically significant uncontrolled condition(s) s described in the protocol.
Clinically significant uncontrolled illness
Subjects with uncontrolled (over the last 30 days) clinically significant confounding medical conditions
Symptomatic arrhythmia
-  Participant has clinically significant uncontrolled condition(s) as described in the protocol.
History or evidence of current clinically significant uncontrolled arrhythmias
Subjects with uncontrolled (over the last 30 days) clinically significant confounding medical conditions
Uncontrolled cardiac arrhythmia
Clinically significant uncontrolled condition(s).
NYHA Class III or IV, uncontrolled hypertension, or clinically significant arrhythmia
Serious uncontrolled cardiac arrhythmia grade II or higher according to NYHA
Significant cardiac arrhythmia
clinically significant symptomatic arrhythmia despite anti-arrhythmic therapy.
Clinically significant cardiovascular disease (e.g., uncontrolled or any NYHA Class 3 or 4 CHF, uncontrolled angina, history of MI, unstable angina or stroke within 6 months prior to study entry, uncontrolled hypertension or clinically significant arrhythmias not controlled by medication).
Clinically significant uncontrolled condition(s)
No arrhythmia interpreted by the study cardiologist to be clinically significant
Uncontrolled clinically significant arrhythmias
Symptomatic and/or serious uncontrolled arrhythmia
Uncontrolled cardiac arrhythmia
Serious uncontrolled cardiac arrhythmia.
Ongoing, significant , uncontrolled medical condition.
Any clinically significant and uncontrolled major medical condition
A history or evidence of current clinically significant uncontrolled arrhythmias;
Current, serious, clinically significant cardiac arrhythmias, defined as the existence of an absolute arrhythmia or ventricular arrythmias classified as Lown III, IV or V.
Clinically significant and uncontrolled major medical condition(s) including but not limited to:
Uncontrolled arrhythmia or symptomatic cardiac or pulmonary disease
Uncontrolled clinically significant arrhythmia in last 6 months.
Any significant medical condition that would preclude them from exercising (e.g., congestive heart failure, angina, uncontrolled arrhythmia or other symptoms that indicate increased risk for an acute cardiovascular or respiratory event)
Clinically significant uncontrolled condition(s).
Symptomatic tachycardia and uncontrolled hypertension (determined to be clinically significant by the PI)
Symptomatic tachycardia and uncontrolled hypertension (determined to be clinically significant by the PI)
History of cardiac arrhythmia, controlled or uncontrolled, including ventricular and supraventricular arrhythmia
Patients must not have had a clinically significant cardiac event within 6 months before entry; or the presence of any other uncontrolled cardiovascular conditions that, in the opinion of the Investigator, increases the risk of ventricular arrhythmia.
Symptomatic arrhythmia or any uncontrolled arrhythmia requiring ongoing treatment.